CFO LeBlanc Buys $136K of Greenland Mines Stock at $9.72
GRML sits 18% above its 52-week low of $7.815 on elevated volume (6.8× avg).
Summary
CFO Jeff LeBlanc bought $136,080 of Greenland Mines stock at $9.72 per share, increasing his direct holdings to 110,406 shares.
Key Events · Ownership and Investor Activity · GRML
-
CFO Buys $136K of Stock
Jeff LeBlanc purchased 14,000 shares at $9.72 per share for $136,080 on August 25, 2026.
-
Stake Rises to 110,406 Shares
Post-transaction direct holdings total 110,406 shares, following a prior 1.4 million share purchase on July 17 at $0.1752 (pre-split).
-
Second Purchase in Five Weeks
This is LeBlanc's second open-market buy since July 17, 2026, signaling continued insider accumulation.
-
Post-Reverse-Split Timing
The purchase occurred one day after the 1-for-50 reverse split took effect on August 24, 2026.
Analysis · GRML · Life Sciences
CFO Jeff LeBlanc bought 14,000 shares for $136,080 at $9.72 on August 25, 2026, lifting his direct stake to 110,406 shares. This is his second open-market purchase in five weeks — he bought 1.4 million shares for $245,280 at $0.1752 on July 17, before the 1-for-50 reverse split. The new purchase comes one day after the reverse split took effect and on the same day the company released a maiden S-K 1300 Initial Assessment for its Sarfartoq rare earth project. Against a backdrop of going-concern doubts and a Nasdaq delisting deadline, the CFO putting fresh cash to work is a meaningful insider conviction signal.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 29.6% of the 2856 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.04%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GRML was trading at $9.24 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $29.4M. The 52-week trading range was $7.82 to $39.45. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.